Cruse Michael 4
4 · Reneo Pharmaceuticals, Inc. · Filed Mar 4, 2022
Insider Transaction Report
Form 4
Cruse Michael
Senior VP-Corporate Operations
Transactions
- Award
Stock option (right to buy)
2022-03-02+25,000→ 25,000 totalExercise: $4.58Exp: 2032-03-01→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares vest in a series of 48 successive equal monthly installments measured from March 2, 2022, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.